Dillon Corrigan

3PUBLICATIONS
34CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.

Courtney D DiNardo, Amir T Fathi, Ashwin Kishtagari

|Feb 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.

Emily Chan, Jesse K McKenney, Sarah Hawley

Pageof 1